COMMUNIQUÉS West-GlobeNewswire

Sapu Nano to Launch Deciparticle™ Platform and Present Clinical Pipeline at BIO-Europe Spring 2026
24/03/2026
AGOURA HILLS, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today that its subsidiary [...]
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
24/03/2026
RADNOR, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic [...]
Addgene and Plasmidsaurus Announce Strategic Partnership to Scale Sequencing for Leading Plasmid Repository
24/03/2026
Strategic partnership to ensure delivery of scalable, cost-effective, and reliable plasmid sequencing as Addgene’s repository expands WATERTOWN, Mass. and SAN FRANCISCO, March 24, 2026 (GLOBE NEWSWIRE) -- Addgene , an [...]
Callio Therapeutics Doses First Patient in Phase I Clinical Trial of Dual-Payload ADC CLIO-8221 in Advanced HER2-Expressing Solid Tumors
24/03/2026
Callio Therapeutics is actively developing a pipeline of promising dual-payload ADCs featuring rationally designed payload combinations for hard-to-treat tumors CLIO-8221 is the first program from Callio Therapeutics [...]
Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development
24/03/2026
MILPITAS, Calif. and THE WOODLANDS, Texas, March 24, 2026 (GLOBE NEWSWIRE) -- Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and [...]
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.
24/03/2026
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, March 24, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc . (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and [...]
Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials
24/03/2026
SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today [...]
Leapfrog Bio Appoints Alan Ashworth, Ph.D., FRS, to Chair Company’s Scientific Advisory Board
24/03/2026
-- Dr. Ashworth Brings Decades of Scientific and Clinical Experience Translating Synthetic Lethality Discoveries into Precision Cancer Therapies -- SOUTH SAN FRANCISCO, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- [...]
TOMI Environmental Solutions Disrupts the Dairy Industry with Major Mexican Dairy Brand
24/03/2026
Rigorous Pathogen Testing and Proven Preservation Results Drive SteraMist Adoption at Major Mexican Dairy Facility FREDERICK, Md., March 24, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ [...]
MINES and Associates COO Recognized as 2026 Colorado Titan 100 Recipient
24/03/2026
LITTLETON, Colo., March 24, 2026 (GLOBE NEWSWIRE) -- MINES and Associates (MINES) is proud to announce that its Chief Operating Officer, Myron Unruh, has been named a 2026 Colorado Titan 100 recipient, an honor that [...]
BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer
24/03/2026
Presentations showcase progress in BioNTech’s late-stage lung cancer programs, reinforcing the potential of the Company’s differentiated portfolio spanning immunomodulators, antibody-drug conjugates, mRNA cancer [...]
Compliance With Nasdaq Periodic Filing Requirement
24/03/2026
Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that based on the Company’s amended annual report on [...]
Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
24/03/2026
CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year research collaboration [...]
iDEL Therapeutics Appoints Claudia Ulbrich as Chair of its Board of Directors
24/03/2026
Dortmund, Germany, March 24, 2026 – iDEL Therapeutics today announced the appointment of accomplished biopharmaceutical executive Claudia Ulbrich, MD, as the Chair of its Board of Directors. Dr. Ulbrich brings over 25 [...]
Zymeworks Announces Participation in Upcoming Investor Conferences
24/03/2026
VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, [...]
Transactions in connection with share buy-back program
24/03/2026
Company announcement no. 6 - 26 24 March 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Serina Therapeutics to Present at the 38th Annual Roth Conference
24/03/2026
HUNTSVILLE, AL, March 24, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology [...]
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
24/03/2026
March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025. Philips’ platform-based solutions [...]
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
24/03/2026
Inclusion in U.S. CRSP ® benchmark indices triggers mandatory position-building by passive index funds tracking more than $3 trillion in AUM, including the world’s largest mutual fund Expands market presence across the [...]

Pages